BioCentury
ARTICLE | Company News

AmVac infectious news

July 1, 2013 7:00 AM UTC

AmVac received two five-year grants to develop vaccines under the EU's Framework Programme 7 (FP7). The projects are part of initiatives that include other companies and research institutes. The first...